Press release
DMF Group and Corporate Finance Associates jointly advised leading research software company a-tune software AG on acquisition by US-based Transnetyx
Frankfurt, Austin (Tx), March 29, 2022DMF Group, Frankfurt and Corporate Finance Associates, Austin (Tx), globally leading M&A advisors for mid-market transactions, advised a-tune software AG, Darmstadt, on its acquisition by Transnetyx, Inc., Memphis, TN (USA).
a-tune is a leading global provider of software for animal research facility management and research compliance. Since 1998, a-tune has been supporting facilities and companies worldwide in the biomedical, pharmaceutical, chemical, biotechnology, and materials science industries to simplify their data management, streamline operations, and ensure compliance with rules and regulations. a-tune's customers comprise more than 140 research facilities, including 100 world-renowned universities and five of the world's seven largest pharmaceutical companies.
Memphis-based Transnetyx is a service provider for genetic research. The company boasts technologies and processes to provide faster, easier, and more accurate results to biomedical researchers. For example, Transnetyx launched the world's first fully automated genotyping system. Since then, Transnetyx has processed more than 30 million samples with 99.97 percent accuracy. The company's other services also include genetic monitoring, microbiome analysis, and supplementary software products.
Transnetyx is a portfolio company of St. Louis-based private equity fund Thompson Street Capital Partners. Thompson Street Capital Partners specializes in the life sciences, health care, and software sectors and has invested more than USD 2.6 billion in over 150 companies to date.
Together, a-tune and Transnetyx become the absolute global leader in research service provision, covering the entire research process from colony management and genotyping to monitoring compliance with the highest ethical and regulatory requirements.
"We are very pleased that Transnetyx has emerged as the most suitable acquirer in the course of the structured sales process we conducted globally. This transaction will enable a-tune to realize a strong growth spurt in the US, by far the world's leading research market. In the course of the transaction, we worked closely with our US colleagues at Corporate Finance Associates. The a-tune transaction underlines the efficiency of our global network," state the two managing partners of DMF Group, Dr. Patrick Schmidl and Michael Dirkes.
Jim Gerberman, Managing Director of Corporate Finance Associates in Austin, TX adds: "With our combined European-based and US-based senior advisors, our team was and is uniquely positioned to provide substantial experience and expertise that addresses the needs of our European- based client- operating under German laws, German taxes and business practices, along with a substantial number of American-based potential buyers. These unique skills were frequently helpful in enabling all parties to make informed decisions and find common ground throughout the process."
"With DMF Group and its US-Partner Corporate Finance Associates, we absolutely had the right partner at our side, the one you need to be able to successfully conclude a company sale. An optimal result was achieved for our company and its shareholders. Transnetyx and a-tune have been partners in science for many years. I am very excited about the opportunities ahead and our future together," says Andreas Staubi, the CEO of a-tune software AG.
Deutsche Mittelstandsfinanz GmbH
Dr. Patrick Schmidl
Eysseneckstr. 4
60322 Frankfurt
Tel. 0049-69-9542-1264
www.dmfin.com
DMF Group, is a leading consulting firm specializing in corporate transactions in the SME sector. The focal points of DMF Group / Deutsche Mittelstandsfinanz include the provision of advice on mergers & acquisitions and corporate succession. Deutsche Mittelstandsfinanz is the German partner of Corporate Finance Associates, an M&A consultancy boasting nearly 40 offices worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release DMF Group and Corporate Finance Associates jointly advised leading research software company a-tune software AG on acquisition by US-based Transnetyx here
News-ID: 2590707 • Views: …
More Releases from Deutsche Mittelstandsfinanz GmbH

Deutsche Mittelstandsfinanz advises on the sale of frobese GmbH to Norwegian Dat …
Deutsche Mittelstandsfinanz (www.dmfin.com) from Frankfurt, which specialises in company sales and succession planning for medium-sized companies, advised the shareholders of frobese GmbH, Hanover, on the sale of their shares to Data Respons AS, Høvik, Norway, a subsidiary of the Belgian-French IT group AKKA Technologies SE. Deutsche Mittelstandsfinanz acted as exclusive M&A consultant to the shareholders of frobese GmbH in the transaction.
frobese GmbH is a leading IT service provider for…

Deutsche Mittelstandsfinanz advises on the sale of the Italian Laica Group to th …
Deutsche Mittelstandsfinanz from Frankfurt, which specialises in M&A transactions and succession planning for medium-sized companies, exclusively advised Laica S.p.A. from Vicenza (Italy) in a structured international sales process. In the course of this sales process, Laica S.p.A., including its subsidiaries in Taiwan and Spain and a 45% stake in a joint venture in China, was sold to the London Stock Exchange-listed Strix Group Plc with registered office in Douglas, Isle…
More Releases for Transnetyx
Genotyping Global Market Report 2024 - By Size, Share, Industry Report, Forecast …
"The new report published by The Business Research Company, titled Genotyping Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the genotyping market size has grown rapidly in recent years. It will grow from $19.71 billion in 2023 to…
Genotyping Market Size, Key Analysis And Growth Report Forecast Report 2024 To 2 …
The genotyping market size has grown rapidly in recent years. It will grow from $19.71 billion in 2023 to $22.9 billion in 2024 at a compound annual growth rate (CAGR) of 16.2%. The growth in the historic period can be attributed to government initiatives and funding, rapid decline in genotyping costs, expansion of biobanks and genetic databases, increasing prevalence of genetic disorders, pharmacogenomics and drug development..
The genotyping market…
Genotyping Market Size, Share Estimation, Business Strategies, Top Trends, Oppor …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Genotyping Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The genotyping market size has grown rapidly in recent years. It will grow…
Global Genotyping Market Growth Prospects, Future Industry Landscape 2033 | F. H …
"The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company presents an extensive market research report on the Genotyping Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing…
Genotyping Global Market is Expected to Reach $36.35 Billion at a CAGR of 16.5% …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Genotyping Global Market Report 2023 identifies the rising prevalence of cancer and genetic disorders is expected to propel the growth of the genotyping market going forward. Cancer refers to a broad collection of illnesses that can begin in practically any organ or tissue…
Genotyping Market: Size, Growth, Share, Trends, Competitive Landscape, Forecast …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Genotyping Global Market Report 2023 identifies rising prevalence of cancer and genetic disorders as the major driver for the Genotyping market's growth in the forecast period. Cancer refers to a broad collection of illnesses that can begin in practically any organ or tissue…